H.R. 661
119th Congress
MIRACLE Medical Technology Act of 2025
3
Cosponsors
3
Actions
0
Amendments
0
Committees
—
Since introduced
Referred to the House Committee on Energy and Commerce.
23 January 2025·1 year ago
Summary
Introduced in House · Updated 2 April 2025
Maximizing Israel-U.S. Research Advancement and Collaborative Leadership in Emerging Medical Technology Act of 2025 or the MIRACLE Medical Technology Act of 2025
This bill requires the Department of Health and Human Services (HHS) to implement a program for the United States and Israel to collaborate on developing and delivering health care products and services. The program must include coordinated activities in specified areas, including research and development, use of innovative technology, intellectual property protection, regulatory harmonization, disease prevention, and biological product manufacturing. The bill authorizes HHS to establish a joint United States-Israel Health Care Collaboration Center in the United States to leverage existing expertise for advancing the program’s purposes.
Timeline
3 actions
Referred to the House Committee on Energy and Commerce.
23 January 2025 · IntroReferral
Introduced in House
23 January 2025 · IntroReferral
Introduced in House
23 January 2025 · IntroReferral
Sponsorship
3 cosponsors
Sponsor
Republican:Rep. Buchanan, Vern [R-FL-16]FLCosponsors
- Democrat267%
- Republican133%
- Democrat:Rep. Suozzi, Thomas R. [D-NY-3]NY
- Democrat:Rep. Soto, Darren [D-FL-9]FL
- Republican:Rep. Miller-Meeks, Mariannette [R-IA-1]IA
Classification
Policy area
HealthLegislative subjects
Cosponsor momentum
Cumulative over time
Cosponsors grew from 2 on 23 January 2025 to 3 on 23 December 2025.
Track MIRACLE Medical Technology Act of 2025 as it moves through Congress
Get alerts on votes, amendments, and stock-market impact